PFO Amplatzer Market Size, Share, Growth Analysis, By Type(Amplatzer PFO Occluder), By Application(Hospitals, Clinics) - Industry Forecast 2024-2031


Report ID: SQSG35A2066 | Region: Global | Published Date: July, 2001
Pages: 221 | Tables: 61 | Figures: 61

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

PFO Amplatzer Market is valued at USD 154.71 Million in 2019, and it is anticipated to attain a value of USD 337.76 Million by 2031, at a CAGR of 11.8% over the forecast period (2024-2031).

The PFO Amplatzer Market is highly consolidated, with the existence of limited number of major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Abbott, WL Gore and Associates, Cardia Inc., and Occlutech among others who are driving the market. 'Abbott (U.S.)', 'W. L. Gore & Associates (U.S.)', 'Occlutech (Switzerland)', 'Starway Medical Technology (U.S.)', 'Cardia Inc. (U.S.)', 'Lifetech Scientific Co. Ltd. (China)'

PFO Amplatzer market is significantly determined by the high occurrence of ischemic stroke. Stroke is the second most normal reason for death on the planet. As per the American Stroke Association, 2016, every year a greater number of than 795,000 individuals in U.S. experience the ill effects of stroke, of which around 87% of stroke are ischemic strokes. Growing adoption of way of life related risk factors, such as, smoking, liquor, drugs or sedentary way of life is supposed to surge the risk of stroke occurrence.

PFO Amplatzer Occluder demand is significantly determined by the high occurrence of ischemic stock. Stroke is the second most normal reason for death on the planet. Growing adoption of standard of living related risks, such as, smoking, liquor, drugs or sedentary way of life is supposed to surge the risk of stroke. Moreover, expanding number of congenital heart illness is supposed to push development of the PFO closure devices.

North America holds the dominant market share credited to the high occurrence of ischemic stroke in the region. Food consumption habits and changing lifestyle among consumers coupled with high disposable income is causing an growing percentage of cardiovascular diseases and heart attacks. These ailments are one of the key factors boosting the growth of the PFO Amplatzers in the forecast timeframe.

Feedback From Our Clients

Global PFO Amplatzer Market

Product ID: SQSG35A2066

$5,300
BUY NOW GET FREE SAMPLE